R531 (Divalproex Sodium Delayed-Release 500 mg)

Pill with imprint R531 is Pink, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R531

Divalproex Sodium Delayed-Release

Imprint:

R531

Strength:

500 mg

Color:

Pink

Size:

19.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Dr. Reddy’s Laboratories Inc.

National Drug Code (NDC):

55111-0531

Inactive Ingredients:

• acetone
• hypromellose
• hypromellose phthalate (31% phthalate, 40 cst)
• isopropyl alcohol
• methylene chloride
• microcrystalline cellulose
• povidone
• corn starch
• silicon dioxide
• magnesium silicate
• titanium dioxide
• vanillin
• shellac
• ferrosoferric oxide
• butyl alcohol
• soya lecithin
• ferric oxide red

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer